Availability of the Skeletonized Gastroepiploic Artery as a Free Graft for Coronary Artery Bypass Grafting.
- Author:
Sang Wan RYU
1
;
Byong Hee AHN
;
Seong Beom HONG
;
Sang Yun SONG
;
In Suk JUNG
;
Min Sun BEOM
;
Jung Min PARK
;
Kyo Sun LEE
;
Sang Woo RYU
;
Ju Sik YOON
;
Sang Hyung KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School. bhahn@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Coronary artery bypass;
Conduits;
Graft;
Gastroepiploic artery graft
- MeSH:
Coronary Artery Bypass*;
Coronary Stenosis;
Coronary Vessels*;
Female;
Follow-Up Studies;
Gastroepiploic Artery*;
Humans;
Postoperative Period;
Skeleton*;
Transplants*
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2005;38(9):601-608
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: To maximize the histological advantage and minimize the physiological disadvantage, we have been using the skeletonized gastroepiploic artey (GEA) as a free graft for total arterial revascularization. The aims of the current study was to assess the efficacy of the skeletonized GEA as a composite or extended graft for total arterial revascularization. MATERIAL AND METHOD: Between January 2000 and Feburary 2005, 133 patients (43 female, mean age=61.8 yrs) undergoing coronary artery bypass grafting (CABG) with a skeletonized GEA as free graft (22 extended, 107 composite and 4 others) were enrolled in this study. Coronary angiograms were performed in the immediate (median 14 days, n=86), early (median 366 days, n=56) and midterm (median 984 days, n=29) postoperative periods. RESULT: There were 3 (2.2%) early and 4 (3.3%) late cardiac-related deaths. The mean number of distal anastomoses per patient was 3.34 for total graft and 1.92 for GEA graft. The immediate, early, and midterm GEA patency were 157/159 (98.7%), 106/112 (94.6%), and 53/56 (94.6%), respectively. During follow-up, four patients required percutaneous intracoronary intervention because of GEA and target coronary artery stenosis or competitive flow. CONCLUSION: These data demonstrate satisfactory clinical and angiographic results in the skeletonized GEA as free graft for total arterial revascularization. Although we need a careful longer follow-up, the skeletonized GEA as a free graft will be a valuable option 'to be' for CABG.
